7581 - 7590 of 7861 Results
Title
Year
- Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson Disease2010RESTRICTEDTitle: Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson DiseaseJournal Name: NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 67Issue #: 5Start Page: 1377End Page: 1385Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1227/neu.0b013e3181f53a5cCitation Count: 61
-
RESTRICTEDTitle: A comparative study of Lrrk2 function in primary neuronal culturesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 16Issue #: 10Start Page: 650End Page: 655Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2010.08.018Best OA location URL: https://europepmc.org/articles/pmc3159957?pdf=renderCitation Count: 80
- Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease2010RESTRICTEDTitle: Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 226Issue #: 1Start Page: 207End Page: 217Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.09.001Best OA location URL: https://europepmc.org/articles/pmc3108022?pdf=renderCitation Count: 53
-
RESTRICTEDTitle: Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairmentJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 120Issue #: 6Start Page: 827End Page: 828Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-010-0744-4Best OA location URL: https://europepmc.org/articles/pmc3100801?pdf=renderCitation Count: 79
- Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease2010RESTRICTEDTitle: Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1367Issue #:Start Page: 310End Page: 318Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.08.099Best OA location URL: https://europepmc.org/articles/pmc3005012?pdf=renderCitation Count: 48
-
RESTRICTEDTitle: CSF Aβ42 and tau in Parkinson's disease with cognitive impairmentJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2682End Page: 2685Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23287Best OA location URL: https://europepmc.org/articles/pmc2978754?pdf=renderCitation Count: 168
-
RESTRICTEDTitle: LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2536End Page: 2541Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23314Best OA location URL: https://europepmc.org/articles/pmc2978749?pdf=renderCitation Count: 62
- A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys2010RESTRICTEDTitle: A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeysJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 39Issue #: 3Start Page: 352End Page: 361Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.05.001Citation Count: 149
-
RESTRICTEDTitle: Systemic Weakness After Therapeutic Injections of Botulinum Toxin AJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 33Issue #: 5Start Page: 243End Page: 247Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0b013e3181f5329eBest OA location URL: https://europepmc.org/articles/pmc3563356?pdf=renderCitation Count: 79
- Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization2010RESTRICTEDTitle: Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localizationJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 430Issue #: 3Start Page: 405End Page: 413Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/bj20100784Best OA location URL: https://portlandpress.com/biochemj/article-pdf/430/3/405/664434/bj4300405.pdfCitation Count: 367